Abstract
Abstract Immunocompromised patients frequently present a prolonged viral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA detection in respiratory samples and are unrecognized sources of transmission. It is therefore important to determine their infectivity potential to establish the adequate follow-up and quarantine measures. We present a test-based strategy to follow up an immunocompromised patient fully vaccinated for SARS-CoV-2, diagnosed with COVID-19 that 3 months after reaching the clinical criteria of cure presented a reduced cycle threshold value in a real-time polymerase chain reactive SARS-CoV-2 test and a positive antigen SARS-CoV-2 test, while being asymptomatic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
